Inventor · disambiguated record
Xiaohong Sheng
Also filed as: SHENG XIAOHONG
29 granted patents·5 pending applications·25 citations·filing 2009–2023
93Inventor score
Files withHANGZHOU SOLIPHARMA CO LTD19HANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD9HANGZHOU PUSHAI PHARMACEUTICAL TECHNOLOGY CO LTD3MOUSSA ADEL M1SOLIPHARMA LLC1
Top patents by PatentIndex Score
34 records- 0191US9562024B2Vortioxetine salt and crystal thereof, their preparation method, pharmaceutical compositions and usageHANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD·Filed 2016·Granted Feb 7, 2017·8 cites·20 claims
- 0288US10899770B2Crystal form of ACP-196 salt and preparation method, pharmaceutical composition, and use thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2017·Granted Jan 26, 2021·4 cites·14 claims
- 0383US9453011B2Crystal form of dabrafenib mesylate and preparation method thereofHANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Sep 27, 2016·3 cites·9 claims
- 0476US9518059B2Inhibitor crystalline form and preparation method and use thereofHANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Dec 13, 2016·2 cites·28 claims
- 0575US10899767B2Crystal form of ACP-196, preparation method therefor and pharmaceutical composition thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2016·Granted Jan 26, 2021·1 cites·7 claims
- 0675US10174010B2Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereofHANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD·Filed 2014·Granted Jan 8, 2019·2 cites·19 claims
- 0772US10669256B2Crystalline forms of lasmiditan, preparation methods, pharmaceutical compositions and uses thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2016·Granted Jun 2, 2020·1 cites·28 claims
- 0872US9884856B2Crystal form of Dabrafenib mesylate and preparation method thereofHANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD·Filed 2016·Granted Feb 6, 2018·1 cites·20 claims
- 0972US9181243B2Solvate form M of trametinib dimethyl sulfoxide and methods of making and using thereofHANGZHOU PUSHAI PHARMACEUTICAL TECHNOLOGY CO LTD·Filed 2014·Granted Nov 10, 2015·2 cites·23 claims
- 1071US10954223B2Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2019·Granted Mar 23, 2021·0 cites·6 claims
- 1171US10954210B2Crystal form of tipifarnib and preparation method and pharmaceutical composition thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2016·Granted Mar 23, 2021·1 cites·24 claims
- 1268US11919906B2Crystal form of ACP-196 and method of treatment thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2020·Granted Mar 5, 2024·0 cites·20 claims
- 1365US12103925B2Crystal and amorphous form of tolebrutinib, preparation method therefor, and use thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2023·Granted Oct 1, 2024·0 cites·24 claims
- 1465US2021163457A1Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1560US11286259B2Co-crystals of ribociclib and co-crystals of ribociclib monosuccinate, preparation method therefor, compositions thereof, and uses thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2018·Granted Mar 29, 2022·0 cites·27 claims
- 1660US2024270733A1Hydrate form of lazertinib mesylate, preparation method thereof and use thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1759US11236077B2Fruquintinib eutectic crystal, preparation method therefor, composition, and uses thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2018·Granted Feb 1, 2022·0 cites·29 claims
- 1857US11639341B2Crystal form of tipifarnib and method of treatment thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2020·Granted May 2, 2023·0 cites·24 claims
- 1957US11236073B2ODM-201 crystalline form, preparation method therefor, and pharmaceutical composition thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2017·Granted Feb 1, 2022·0 cites·20 claims
- 2056US9458149B2Crystal form of dabrafenib and preparation method and use thereofHANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD·Filed 2016·Granted Oct 4, 2016·0 cites·14 claims
- 2154US11208382B2Entinostat-containing compound, crystal form of compound thereof, and preparation method therefor and pharmaceutical composition thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2017·Granted Dec 28, 2021·0 cites·12 claims
- 2254US2016200698A1Vortioxetine salt and crystal thereof, their preparation method, pharmaceutical compositions and usageHANGZHOU PUSHAI PHARMACEUTICAL TECHNOLOGY CO LTD·Filed 2014·Application pending·0 cites
- 2353US11111248B2Crystal form of 2-(6-methyl-pyridin-2-yl)-3-yl-[6-amido-quinolin-4-yl]-5,6-dihydro-4H-pyrrolo[1,2-B]pyrazole, preparation method therefor and pharmaceutical composition thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2017·Granted Sep 7, 2021·0 cites·20 claims
- 2453US8470870B2Solid forms of an anti-HIV phosphoindole compoundMOUSSA ADEL M·Filed 2009·Granted Jun 25, 2013·0 cites·46 claims
- 2550US9708301B2Crystalline forms of afatinib monomaleate, preparation methods and pharmaceutical compositions thereofHANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD·Filed 2016·Granted Jul 18, 2017·0 cites·12 claims
- 2650US9365559B2Crystal form of Dabrafenib and preparation method of use thereofHANGZHOU PUSHAI PHARMACEUTICAL TECHNOLOGY CO LTD·Filed 2015·Granted Jun 14, 2016·0 cites·15 claims
- 2748US10995083B2Cocrystal of 2-(6-methyl-pyridine-2-yl)-3-yl-[6-amide-quinoline-4-yl]-5,6-dihydro-4H-pyrrole[1,2-b]pyrazole, preparation method therefor, and pharmaceutical compositionHANGZHOU SOLIPHARMA CO LTD·Filed 2017·Granted May 4, 2021·0 cites·14 claims
- 2847US10189870B2Crystalline form of oxazolidinone antibiotics and preparation method, composition and use thereofHANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Jan 29, 2019·0 cites·15 claims
- 2947US9981912B2Cocrystal of lorcaserin, preparation methods, pharmaceutical compositions and uses thereofHANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted May 29, 2018·0 cites·17 claims
- 3045US10759798B2ABT-199 addition salt and crystal form thereof, preparation method thereof, and pharmaceutical composition thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2016·Granted Sep 1, 2020·0 cites·21 claims
- 3144US11117875B2Crystalline forms, preparation methods and pharmaceutical compositions of ozanimodHANGZHOU SOLIPHARMA CO LTD·Filed 2016·Granted Sep 14, 2021·0 cites·17 claims
- 3243US11427528B2Fenofibrate crystalline form and manufacturing method thereofUNIV ZHEJIANG TECHNOLOGY·Filed 2016·Granted Aug 30, 2022·0 cites·14 claims
- 3341US2021179585A1Crystal form of abemaciclib mesylate, preparation method therefor and pharmaceutical composition thereofHANGZHOU SOLIPHARMA CO LTD·Filed 2018·Application pending·0 cites
- 3436US2020031784A1Ozanimod addition salt crystal, preparation method, pharmaceutical composition, and usesSOLIPHARMA LLC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiaohong Sheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →